Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Shares withheld for taxes COO and SVP, Compliance gave up 1,854 shares (to pay taxes)
  2. 4 Shares withheld for taxes President and CEO gave up 14,343 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Option exercise Director acquired 9,000 shares (option exercise)
  6. 4 Open-market sale CFO and Treasurer sold 15,000 shares at $21.15 ($317,250)
  7. 4 Open-market sale President and CEO sold 48,967 shares at $21.10 ($1,033,204)
  8. 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,647 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 21,752 shares (to pay taxes)
  10. 4 Open-market sale Director sold 9,000 shares at $18.47 ($166,189)
  11. 4 Open-market sale COO and SVP, Compliance sold 24,150 shares at $16.90 ($408,050)
  12. 4 Open-market sale Director sold 136,861 shares at $17.27 ($2,363,932)
  13. 4 Open-market sale President and CEO sold 626,245 shares at an average $17.44 ($10,923,987)
  14. 4 Open-market sale Director sold 60,000 shares at $18.26 ($1,095,600)
  15. 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,502 shares (to pay taxes)
  16. 4 Grant or award CFO and Treasurer acquired 72,400 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,085 shares (to pay taxes)
  19. 4 Shares withheld for taxes President,CEO, and Interim CFO gave up 21,752 shares (to pay taxes)
  20. 4 Open-market sale President,CEO, and Interim CFO sold 100,000 shares at $10.72 ($1,071,980)

Page 4 of 19 · 362 filings